# BioCritica, Inc. — Form D

BioCritica, Inc. of INDIANAPOLIS, IN, a company, filed a Form D exempt-offering notice with the SEC on 2011-05-26. The offering totals $25.0M, of which $25.0M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2011-05-26
- Form: D
- Accession: 0001521626-11-000001
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $25.0M
- Amount sold: $25.0M
- Investors: 4
- Date of first sale: 2011-05-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-160380

## Issuer

- Name: BioCritica, Inc.
- CIK: 0001521626
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 8888 KEYSTONE CROSSING, INDIANAPOLIS, IN, 46240
- Phone: 317-575-4035

## Officers, directors & promoters (10)

| Name | Role | Location |
| --- | --- | --- |
| MICHAEL J BOLOGNA | Director | RALEIGH, NC |
| David A Broecker | Director | Zionsville, IN |
| DARREN J CARROLL | Director | INDIANAPOLIS, IN |
| MIKE F JOHNSON | Director | INDIANAPOLIS, IN |
| ARGERIS N KARABELAS | Director | PRINCETON, NJ |
| Lorenzo N Pellegrini | Director | Princeton, NJ |
| Ronald J Wooten | Director | Raleigh, NC |
| David A Broecker | Executive Officer | Zionsville, IN |
| MICHAEL D PAGNOTTA | Executive Officer | INDIANAPOLIS, IN |
| MARK D WILLIAMS | Executive Officer | INDIANAPOLIS, IN |

## More

- [CIK 1521626 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1521626&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001521626-11-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.